LGND
LGND
NASDAQ · Pharmaceuticals

Ligand Pharmaceuticals

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$204.56
+2.90 (+1.44%)
As of Mar 25, 9:57 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -84.6% upside
Low Target $18.80
Average Target $31.56
High Target $35.41
Current Price $204.56
Current
$204.56
Target
$31.56
$18.80 $31.56 avg $35.41
Scenario Analysis
Bear Case
$18.80
-90.8%
Low target
Base Case
$31.56
-84.6%
Avg target
Bull Case
$35.41
+-82.7%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$212.49
-3.7% from high
52-Week Low
$93.58
+118.6% from low
50-Day SMA
$193.47
+5.7% vs SMA
200-Day SMA
$162.08
+26.2% vs SMA
RSI (14)
38.7
Neutral
Target vs 52W High
$31.56
-85.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%